Company: HCTI
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026218
Chunk: 172

Company: Healthcare Triangle, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1A
Chunk 172
---
 “Risk Factors.” Many of these factors are
outside of our control. As a result, we may not be able to sustain compliance with the minimum bid price rule in the long term. Any potential
delisting of our common stock from the Nasdaq Capital Market would likely result in decreased liquidity and increased volatility for our
common stock and would adversely affect our ability to raise additional capital or to enter into strategic transactions. Any potential
delisting of our common stock from the Nasdaq Capital Market would also make it more difficult for our stockholders to sell our common
stock in the public market.

The Company and its products are subject to
laws and regulations concerning electronic prescribing standards and the adoption of controlled substance electronic prescribing. Our
actual or perceived failure to comply with these laws and regulations could harm our business, financial condition, results of operations,
reputation, or prospects.

The use of our software by physicians to perform
a variety of functions, including electronic prescribing, which refers to the electronic routing of prescriptions to pharmacies and the
ensuing dispensation, is governed by state and federal law, including fraud and abuse laws. States have differing prescription format
requirements, which we have programmed into our software. There is significant variation in the laws and regulations governing prescription
activity, as federal law and the laws of many states permit the electronic transmission of certain controlled prescription orders, while
the laws of several states neither specifically permit nor specifically prohibit the practice. Restrictions exist at the federal level
on the use of electronic prescribing for controlled substances and certain other drugs, including a regulation enacted by the Drug Enforcement
Association in mid-2010. However, some states (most notably New York) have passed complementary laws governing the use of electronic prescribing
tools in the use of prescribing opioids and other controlled substances, and we expect this to continue to be addressed with regulations
in other states. In addition, the HHS published its final “E-Prescribing and the Prescription Drug Program” regulations in
2005 (effective January 1, 2006), and final regulations governing the standards for electronic prescribing under Medicare Part D in 2008
(effective June 6, 2008) (the “ePrescribing Regulations”). These regulations are required by the Medicare Prescription Drug,
Improvement, and Modernization Act of 2003 (“MMA”) and consist of detailed standards and requirements, in addition to the
HIPAA Standard discussed above, for prescription and other information transmitted electronically in connection with a drug benefit covered
by the MMA’s